Viewing Study NCT00973895


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-03-14 @ 1:43 PM
Study NCT ID: NCT00973895
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2009-09-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 090204
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators